Listeria monocytogenes-associated endovascular infections: A study of 71 consecutive cases.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
10 2019
Historique:
received: 20 02 2019
revised: 19 06 2019
accepted: 26 07 2019
pubmed: 4 8 2019
medline: 25 7 2020
entrez: 4 8 2019
Statut: ppublish

Résumé

Listeria monocytogenes-associated endovascular infections are not well characterized. Retrospective study of 71 culture-proven cases reported to the French National Reference Center for Listeria from 1993 to 2018. Seventy-one cases were identified: 42 with vascular aneurysms/prosthetic infections, 27 with endocarditis, 2 with both. Fifty-eight were men (82%); median age was 75 years [46-92]; 93% reported co-morbidities (66/71), including 50% with immunosuppressive conditions. Vascular infections consisted of infected aneurysms (68%) or prosthetic graft infections (32%); vascular rupture was reported in 25/42 (60%). Tissue samples grew L. monocytogenes in 98% (43/44) and blood cultures in 64% (27/42). Endocarditis cases involved prosthetic or native valves or intracardiac devices in respectively 62% (18/29), 28% (8/29) and 10% (3/29). Infected valves were aortic (62%, 16/26), mitral (31%, 8/26) or both (8%, 2/26); 38% patients required surgery; 45% displayed heart failure; 17% had concomitant neurolisteriosis. In-hospital mortality in vascular infections was 12% (5/42) and 41% (12/29) for Lm-associated endocarditis. Endovascular listeriosis is a rare but severe infection. It manifests as vascular infections and endocarditis, mostly in older patients with vascular or cardiac valve prosthetic devices and co-morbidities. Mortality in Lm-associated endocarditis is twice higher than with other pathogens, requiring prompt recognition and treatment.

Sections du résumé

BACKGROUND
Listeria monocytogenes-associated endovascular infections are not well characterized.
METHODS
Retrospective study of 71 culture-proven cases reported to the French National Reference Center for Listeria from 1993 to 2018.
RESULTS
Seventy-one cases were identified: 42 with vascular aneurysms/prosthetic infections, 27 with endocarditis, 2 with both. Fifty-eight were men (82%); median age was 75 years [46-92]; 93% reported co-morbidities (66/71), including 50% with immunosuppressive conditions. Vascular infections consisted of infected aneurysms (68%) or prosthetic graft infections (32%); vascular rupture was reported in 25/42 (60%). Tissue samples grew L. monocytogenes in 98% (43/44) and blood cultures in 64% (27/42). Endocarditis cases involved prosthetic or native valves or intracardiac devices in respectively 62% (18/29), 28% (8/29) and 10% (3/29). Infected valves were aortic (62%, 16/26), mitral (31%, 8/26) or both (8%, 2/26); 38% patients required surgery; 45% displayed heart failure; 17% had concomitant neurolisteriosis. In-hospital mortality in vascular infections was 12% (5/42) and 41% (12/29) for Lm-associated endocarditis.
CONCLUSIONS
Endovascular listeriosis is a rare but severe infection. It manifests as vascular infections and endocarditis, mostly in older patients with vascular or cardiac valve prosthetic devices and co-morbidities. Mortality in Lm-associated endocarditis is twice higher than with other pathogens, requiring prompt recognition and treatment.

Identifiants

pubmed: 31376457
pii: S0163-4453(19)30238-5
doi: 10.1016/j.jinf.2019.07.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

322-331

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Michka Shoai-Tehrani (M)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Université de Paris, Service de Maladies Infectieuses et Tropicales, Hôpital Universitaire Necker-Enfants Malades, Paris, France.

Benoit Pilmis (B)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Université de Paris, Service de Maladies Infectieuses et Tropicales, Hôpital Universitaire Necker-Enfants Malades, Paris, France.

Mylène M Maury (MM)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France; INSERM U1117, Paris, France.

Olivier Robineau (O)

Centre Hospitalier Universitaire Tourcoing, Paris, France.

Olivier Disson (O)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; INSERM U1117, Paris, France.

Gregory Jouvion (G)

Institut Pasteur, Experimental Neuropathology Unit, Paris, France.

Gabrielle Coulpier (G)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France.

Pierre Thouvenot (P)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France.

Hélène Bracq-Dieye (H)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France.

Guillaume Valès (G)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France.

Alexandre Leclercq (A)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France.

Marc Lecuit (M)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Université de Paris, Service de Maladies Infectieuses et Tropicales, Hôpital Universitaire Necker-Enfants Malades, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France; INSERM U1117, Paris, France. Electronic address: marc.lecuit@pasteur.fr.

Caroline Charlier (C)

Institut Pasteur, French National Reference Center, WHO Collaborating Center for Listeria, Paris, France; Université de Paris, Service de Maladies Infectieuses et Tropicales, Hôpital Universitaire Necker-Enfants Malades, Paris, France; Institut Pasteur, Biology of Infection Unit, 28 rue du Dr Roux, 75015 Paris, France; INSERM U1117, Paris, France. Electronic address: caroline.charlier@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH